BlackRock Inc. Boosts Stock Position in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

BlackRock Inc. increased its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 3.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,735,875 shares of the medical instruments supplier’s stock after buying an additional 458,934 shares during the period. BlackRock Inc. owned 6.57% of DENTSPLY SIRONA worth $859,985,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. Rampart Investment Management Company LLC lifted its position in DENTSPLY SIRONA by 995.9% in the 2nd quarter. Rampart Investment Management Company LLC now owns 29,831 shares of the medical instruments supplier’s stock valued at $1,741,000 after acquiring an additional 27,109 shares in the last quarter. Man Group plc lifted its position in DENTSPLY SIRONA by 160.5% in the 2nd quarter. Man Group plc now owns 930,798 shares of the medical instruments supplier’s stock valued at $54,323,000 after acquiring an additional 573,519 shares in the last quarter. Bank of America Corp DE lifted its position in DENTSPLY SIRONA by 2.0% in the 2nd quarter. Bank of America Corp DE now owns 993,418 shares of the medical instruments supplier’s stock valued at $57,975,000 after acquiring an additional 19,420 shares in the last quarter. JPMorgan Chase & Co. lifted its position in DENTSPLY SIRONA by 70.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 330,810 shares of the medical instruments supplier’s stock valued at $19,066,000 after acquiring an additional 137,163 shares in the last quarter. Finally, Balyasny Asset Management LLC lifted its position in DENTSPLY SIRONA by 2,455.5% in the 2nd quarter. Balyasny Asset Management LLC now owns 576,515 shares of the medical instruments supplier’s stock valued at $33,645,000 after acquiring an additional 553,955 shares in the last quarter. Institutional investors own 93.46% of the company’s stock.

Several equities analysts recently issued reports on the company. BidaskClub cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. Barrington Research reaffirmed a “buy” rating and issued a $63.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, August 5th. ValuEngine cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Evercore ISI assumed coverage on DENTSPLY SIRONA in a research report on Friday, July 26th. They issued an “in-line” rating on the stock. Finally, Wellington Shields raised DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research report on Friday, August 2nd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $55.75.

NASDAQ XRAY opened at $57.42 on Friday. The business’s fifty day moving average price is $53.88 and its 200-day moving average price is $54.19. The stock has a market capitalization of $12.31 billion, a price-to-earnings ratio of 28.57, a PEG ratio of 1.97 and a beta of 0.96. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.08 and a quick ratio of 1.39. DENTSPLY SIRONA Inc has a 1-year low of $34.93 and a 1-year high of $60.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.07. The firm had revenue of $962.10 million for the quarter, compared to analysts’ expectations of $940.38 million. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The company’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.38 EPS. Equities research analysts anticipate that DENTSPLY SIRONA Inc will post 2.39 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Story: What is a put option?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply